Bias found in mental health drug research presented at major psychiatric meeting

May 22, 2012

When thousands of psychiatrists attend their field's largest annual meeting each year, the presentations they hear about research into drug treatments report overwhelmingly on positive results.

That's the finding of a new study published in the Journal of Clinical Psychopharmacology by two young psychiatrists from the University of Michigan and Yale University, who analyzed the presentations given at two recent meetings of the .

Of 278 studies presented at the 2009 and 2010 APA meetings that compared at least two medicines against each other for any , they found that 195 had been supported by industry, and 83 funded by other means. The authors then evaluated the studies without knowing which kind of support each one had.

Of the industry-supported studies, 97.4 percent reported results that were positive toward the medicine that the study was designed to test, and 2.6 percent reported mixed results. No industry-sponsored studies with negative results were found.

In contrast, when industry was not the source of funding, 68.7 percent of the presentations were positive, and 24.1 percent contained mixed results, while 7.2 percent contained negative results.

This 'presentation bias', in which mostly good news about medicines gets reported at meetings, the 'publication bias' that has been seen in research published in major journals, says Srijan Sen, M.D., Ph.D., an assistant professor of psychiatry at the U-M Medical School who led the study while in his residency at Yale.

While attending the APA's massive annual meeting, he noted the large industry presence and emphasis on research involving medicines that were still "on patent" and being actively marketed to both psychiatrists attending the conference. He teamed with Yale psychiatry resident Maya Prabhu, M.D., M.Sc., now a consulting forensic psychiatrist at Yale, to do a formal review.

"This analysis suggests that the APA meeting might be being used as an opportunity to make drugs seem more effective than they are," he says.

Meanwhile, research on "talk therapy" treatments such as cognitive behavioral therapy – which doesn't have industry backing – gets less attention, even though there is growing evidence that such non-drug therapies can have as much effect as medicines in illnesses such as depression.

Since the APA meeting is a major source of continuing medical education credit for psychiatrists, and a hub for psychiatry residents just starting out in the field, the bias has the potential to affect their clinical care when they return home.

Sen notes that the research journals and funding agencies have tried to confront research bias in journal articles by requiring pharmaceutical companies to register the clinical trials they are conducting and include the registration number when publishing the study. This allows interested individuals to see which trials are being reported in the medical literature, and whether the trial results are interpreted according to the original study design.

For instance, if a drug trial is designed to test long-term results from a particular treatment, but a paper is published showing positive over a much shorter term, that could be an indication of bias. Research meetings could require a similar practice, Sen says. And, APA could be more selective in accepting poster presentation submissions.

If nothing else, Sen says, attendees at the APA's meeting – and perhaps other large gatherings of psychiatrists – should be aware of the positive bias of the research they will hear about at the meeting.

And, non-industry funding for research – especially research to compare older "off patent" drugs that aren't being marketed by industry – is also important, he says. The federal government has funded large comparison studies in depression, schizophrenia and bipolar disorder, he notes – and these mostly showed that the generic medications that have lost their patent protection are just as effective as newer, patent-protected ones. But even still, prescribe the generic ones far less often than the brand-name patent-protected ones.

Explore further: Publication bias involving psychiatric medications may provide physicians with an incomplete picture

More information: Journal of Clinical Psychopharmacology, Volume 32, Number 3, June 2012.

Related Stories

Publication bias involving psychiatric medications may provide physicians with an incomplete picture

March 20, 2012
Physicians who prescribe antipsychotic medications may be basing their decisions on incomplete information, according to new research published by scientists at Oregon Health & Science University. The study is published in ...

Recommended for you

Self-harm, suicide attempts climb among US girls, study says

November 21, 2017
Attempted suicides, drug overdoses, cutting and other types of self-injury have increased substantially in U.S. girls, a 15-year study of emergency room visits found.

Simple EKG can determine whether patient has depression or bipolar disorder

November 20, 2017
A groundbreaking Loyola Medicine study suggests that a simple 15-minute electrocardiogram could help a physician determine whether a patient has major depression or bipolar disorder.

Non-fearful social withdrawal linked positively to creativity

November 20, 2017
Everyone needs an occasional break from the social ramble, though spending too much time alone can be unhealthy and there is growing evidence that the psychosocial effects of too much solitude can last a lifetime.

Car, stroller, juice: Babies understand when words are related

November 20, 2017
The meaning behind infants' screeches, squeals and wails may frustrate and confound sleep-deprived new parents. But at an age when babies cannot yet speak to us in words, they are already avid students of language.

Cultural values can be a strong predictor of alcohol consumption

November 20, 2017
Countries with populations that value autonomy and harmony tend to have higher average levels of alcohol consumption than countries with more traditional values, such as hierarchy and being part of a collective. This new ...

A walk at the mall or the park? New study shows, for moms and daughters, a walk in the park is best

November 17, 2017
Spending time together with family may help strengthen the family bond, but new research from the University of Illinois shows that specifically spending time outside in nature—even just a 20-minute walk—together can ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.